Genetic Engineering and Biotechnology

RNA interference (RNAi) utilizes small interfering RNA (siRNA) to target and silence specific gene expression, regulating the production of specific proteins.

Base editing is a gene editing technique that combines CRISPR-Cas9 with engineered enzymes to directly convert one DNA base to another, enabling precise modifications without introducing double-strand breaks.

A major challenge associated with using viral vectors in gene therapy is the potential activation of the immune response, which can lead to vector rejection or adverse effects.

Gene drives are genetic engineering techniques that utilize engineered genetic elements to bias inheritance in favor of a specific allele, enabling the spread of genetic modifications through a population.

The treatment for Gaucher disease is enzyme replacement therapy. This therapy replaces the missing enzyme that is needed to break down Gaucher cells.

CRISPR-Cas9 is a groundbreaking gene-editing tool that enables targeted changes to DNA sequences, offering potential applications in treating genetic diseases and developing novel therapies.

Personalized medicine involves customizing healthcare strategies based on a person's unique genetic makeup, lifestyle, and medical history, aiming to optimize treatment outcomes and reduce adverse effects.

Genome sequencing involves determining the complete sequence of an individual's DNA, enabling the identification of genetic variations and providing insights into disease risks and personalized medicine strategies.

Nanobiotechnology involves the application of nanotechnology to study and manipulate biological systems at the molecular level.

Antibody engineering is the process of modifying the structure or properties of antibodies to improve their therapeutic or diagnostic potential. This can involve altering the antibody's affinity, specificity, stability, or effector functions.

Antibody engineering involves various techniques to modify antibody structure and properties. Site-directed mutagenesis involves introducing specific mutations into the antibody gene to alter its amino acid sequence. CDR grafting involves transferring the CDRs from one antibody to another to create a chimeric antibody with desired properties. Chimeric antibody construction involves combining the variable region of one antibody with the constant region of another antibody to create a chimeric antibody with specific characteristics.

Intellectual property rights play a complex role in the bioeconomy, potentially incentivizing innovation while also creating barriers to access and use of biological resources and leading to the formation of monopolies.

Hydroponics is a method of growing plants without soil, using water and nutrients. It is not a type of food technology.

The Human Genome Project was an international scientific research project with the goal of determining the sequence of nucleotide base pairs that make up human DNA. The project was completed in 2003, and it has had a profound impact on our understanding of human biology and disease.

The 'genomic revolution' refers to the rapid advances in genomic research and technology that have occurred in recent years. These advances have led to a greater understanding of human biology and disease, and they have also raised a number of ethical and social issues.